Mastoparan potently stimulated catalytic activity of
guanylate cyclase-coupled
atrial natriuretic factor receptor (GC-A/
ANF-R), both in the plasma membranes and intact Leydig
tumor (MA-10) cells. In plasma membrane preparations, a maximum of 5-fold GC catalytic activity was stimulated by 100 microM
mastoparan and the half maximum stimulation (EC50) was achieved at 40 microM concentration.
Mastoparan potentiated GC activity by more than 40%, above the level, stimulated by
ANF. Mas 7, an active analog of
mastoparan, stimulated the GC activity in a similar manner to
mastoparan whereas Mas 17, an inactive analog, did not enhance GC activity. In membranes prepared from
mastoparan-treated intact MA-10 cells, GC catalytic activity was enhanced by more than 4-fold as compared with untreated control cells. Pretreatment of membranes with either anti-Gs alpha or anti-Gi alpha
antibodies had no effect on
mastoparan-stimulated GC activity, however, anti-Go alpha
antibodies inhibited the stimulatory effect of
mastoparan by almost 50%. Agents known to modulate the effect of
mastoparan such as
EGTA (Ca2+
chelator),
W7 (
calmodulin inhibitor) and
staurosporine (
protein kinase C inhibitor) had no effect on the
mastoparan-stimulated GC activity.
Mastoparan enhanced the
ANF-stimulated GC activity in
detergent solubilized membrane preparations without a significant change in
ANF-binding capacity. The data establish a role for
mastoparan in the
ANF-dependent stimulation of GC-A/
ANF-R catalytic activity, both in the plasma membrane preparations and intact Leydig
tumor (MA-10) cells. Furthermore, these findings provide new evidence that
mastoparan (isolated from
wasp venom) potently stimulates
guanylate cyclase activity of GC-A/
ANF-R by activating
G-proteins.